Zhejiang Genfleet Therapeutics Co., Ltd. Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2017)

Organization Overview

First Clinical Trial
2020
NCT04588922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

GenFleet Therapeutics (Australia) Pty Ltd. | Zhejiang Genfleet Therapeutics Co., Ltd.